ALKS vs PPL · P/E 14, rev $1.56B vs P/E 22, rev $8.46B
Alkermes Plc (ALKS) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the ALKS and PPL stock pages for the full models.
Not investment advice.